Generic medicines will play a key role in the government's efforts to hold down Medicare prescription drug benefit costs, according to Centers for Medicare & Medicaid Services (CMS) Administrator Mark McClellan, MD, PhD.
Dr. McClellan released new CMS data to Congress suggesting that the cost of Medicare Part D is already significantly lower than originally projected. According to those figures, the net cost to the government for drug coverage in 2006 is expected to be $30.5 billion, down from previous estimates of $38.1 billion. Additionally, premiums for the average individual will be about a third less than previously estimated, at $25 per month. Over 10 years, the program is now expected to weigh in at $70 billion less than originally projected.
In Seniors: Consider CMV Serostatus
When Recommending Flu Vaccine
Older people who have cytomegalovirus seem to have less robust responses to the trivalent influenza vaccine than those who do not have CMV.
News from the year's biggest meetings
Clinical features with downloadable PDFs